Nexalin Technology, Inc. (NXLIW)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.64 Million USD | -141.39% |
| 2022 | -1.92 Million USD | 68.74% |
| 2021 | -6.16 Million USD | -76.91% |
| 2020 | -3.48 Million USD | 30.65% |
| 2019 | -5.02 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.28 Million USD | -23.37% |
| 2024 Q1 | -1.04 Million USD | -33.37% |
| 2023 Q4 | -780.66 Thousand USD | 66.02% |
| 2023 FY | -4.64 Million USD | -141.39% |
| 2023 Q3 | -2.29 Million USD | -179.31% |
| 2023 Q2 | -822.43 Thousand USD | -15.89% |
| 2023 Q1 | -709.64 Thousand USD | 5.66% |
| 2022 Q2 | -433.87 Thousand USD | -5.47% |
| 2022 Q1 | -411.38 Thousand USD | 30.97% |
| 2022 FY | -1.92 Million USD | 68.74% |
| 2022 Q4 | -752.25 Thousand USD | -456.13% |
| 2022 Q3 | -135.26 Thousand USD | 68.82% |
| 2021 Q3 | -1.79 Million USD | 14.29% |
| 2021 FY | -6.16 Million USD | -76.91% |
| 2021 Q4 | -595.92 Thousand USD | 66.89% |
| 2021 Q2 | -2.09 Million USD | -32.67% |
| 2021 Q1 | -1.58 Million USD | -246.1% |
| 2020 Q2 | -1.09 Million USD | 0.0% |
| 2020 FY | -3.48 Million USD | 30.65% |
| 2020 Q4 | -457.27 Thousand USD | 39.63% |
| 2020 Q3 | -757.41 Thousand USD | 30.79% |
| 2020 Q1 | -1.09 Million USD | 0.0% |
| 2019 FY | -5.02 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 92.456% |
| BrainsWay Ltd. | -4.19 Million USD | -10.763% |
| Cerus Corporation | -37.48 Million USD | 87.6% |
| Envoy Medical, Inc. | -29.9 Million USD | 84.457% |
| electroCore, Inc. | -18.83 Million USD | 75.317% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 47.472% |
| IceCure Medical Ltd | -14.65 Million USD | 68.273% |
| Inogen, Inc. | -102.44 Million USD | 95.462% |
| OrthoPediatrics Corp. | -20.97 Million USD | 77.836% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 91.173% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 66.179% |
| MaxCyte, Inc. | -37.92 Million USD | 87.742% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 60.802% |
| Orthofix Medical Inc. | -151.39 Million USD | 96.929% |
| PAVmed Inc | -64.17 Million USD | 92.756% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 91.14% |
| RxSight, Inc. | -48.6 Million USD | 90.436% |
| Sight Sciences, Inc. | -55.54 Million USD | 91.631% |
| SI-BONE, Inc. | -43.33 Million USD | 89.273% |
| TELA Bio, Inc. | -46.66 Million USD | 90.038% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 90.614% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 65.776% |
| Acutus Medical, Inc. | -81.66 Million USD | 94.307% |
| Talis Biomedical Corporation | -62 Million USD | 92.503% |
| Spectral AI, Inc. | -20.85 Million USD | 77.708% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 92.351% |
| CVRx, Inc. | -41.19 Million USD | 88.716% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 826.138% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 57.567% |
| Bioventus Inc. | -156.23 Million USD | 97.024% |
| Venus Concept Inc. | -37.25 Million USD | 87.52% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 92.126% |
| LivaNova PLC | 17.54 Million USD | 126.494% |
| 908 Devices Inc. | -36.39 Million USD | 87.228% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 97.509% |
| Nemaura Medical Inc. | -14.14 Million USD | 67.132% |
| NeuroPace, Inc. | -32.95 Million USD | 85.894% |
| LENSAR, Inc. | -14.38 Million USD | 67.679% |
| Apyx Medical Corporation | -18.71 Million USD | 75.158% |
| Cutera, Inc. | -162.83 Million USD | 97.145% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 57.076% |
| BioSig Technologies, Inc. | -29.04 Million USD | 83.993% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 94.377% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 78.955% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 106.862% |
| Axonics, Inc. | -6.08 Million USD | 23.641% |
| Outset Medical, Inc. | -172.79 Million USD | 97.31% |
| IRIDEX Corporation | -9.57 Million USD | 51.424% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 95.61% |
| IRadimed Corporation | 17.19 Million USD | 127.039% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 43.611% |
| INVO Bioscience, Inc. | -8.03 Million USD | 42.141% |
| Telesis Bio, Inc. | -47.72 Million USD | 90.259% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 145.384% |
| Varex Imaging Corporation | -47.7 Million USD | 90.254% |
| Quipt Home Medical Corp. | -2.78 Million USD | -66.979% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 58.81% |
| Pulmonx Corporation | -60.84 Million USD | 92.36% |
| Dynatronics Corporation | -2.69 Million USD | -72.32% |
| Modular Medical, Inc. | -17.47 Million USD | 73.39% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 59.175% |
| Semler Scientific, Inc. | 20.58 Million USD | 122.585% |
| InMode Ltd. | 197.91 Million USD | 102.349% |
| Bruker Corporation | 427.2 Million USD | 101.088% |
| Cytosorbents Corporation | -28.5 Million USD | 83.693% |
| DexCom, Inc. | 541.5 Million USD | 100.858% |
| Align Technology, Inc. | 445.05 Million USD | 101.045% |
| Viveve Medical, Inc. | -22.02 Million USD | 78.895% |
| ZimVie Inc. | -393.28 Million USD | 98.818% |
| Movano Inc. | -29.28 Million USD | 84.125% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 61.733% |
| Nexalin Technology, Inc. | -4.64 Million USD | -0.0% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 826.138% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 97.912% |
| Profound Medical Corp. | -28.56 Million USD | 83.728% |
| Insulet Corporation | 206.3 Million USD | 102.253% |
| enVVeno Medical Corporation | -23.51 Million USD | 80.232% |
| Surmodics, Inc. | -11.54 Million USD | 59.724% |
| iCAD, Inc. | -4.84 Million USD | 4.091% |
| Nuwellis, Inc. | -20.2 Million USD | 76.997% |
| Biotricity, Inc. | -14.09 Million USD | 67.017% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 96.233% |
| Aethlon Medical, Inc. | -12.2 Million USD | 61.921% |
| InspireMD, Inc. | -19.91 Million USD | 76.658% |
| PAVmed Inc. | -64.17 Million USD | 92.756% |
| BIOLASE, Inc. | -20.63 Million USD | 77.468% |
| Beyond Air, Inc. | -60.24 Million USD | 92.283% |
| FONAR Corporation | 10.56 Million USD | 143.991% |
| AxoGen, Inc. | -21.71 Million USD | 78.593% |
| Vivani Medical, Inc. | -25.65 Million USD | 81.878% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 116.303% |
| Inari Medical, Inc. | -1.63 Million USD | -184.151% |
| UFP Technologies, Inc. | 44.92 Million USD | 110.348% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 9.423% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 29.621% |
| Tenon Medical, Inc. | -15.58 Million USD | 70.164% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 69.864% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 86.843% |
| AdaptHealth Corp. | -678.89 Million USD | 99.315% |
| Sintx Technologies, Inc. | -8.25 Million USD | 43.713% |
| NanoVibronix, Inc. | -3.71 Million USD | -25.268% |
| Quanterix Corporation | -32.33 Million USD | 85.623% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 58.81% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1058.497% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.484% |
| TransMedics Group, Inc. | -25.02 Million USD | 81.426% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 78.996% |
| NeuroMetrix, Inc. | -6.52 Million USD | 28.804% |
| Hyperfine, Inc. | -44.23 Million USD | 89.492% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 94.078% |
| Biomerica, Inc. | -5.97 Million USD | 22.236% |
| Bone Biologics Corporation | -8.94 Million USD | 48.052% |
| AVITA Medical, Inc. | -39.16 Million USD | 88.131% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 53.298% |
| Silk Road Medical, Inc | -55.74 Million USD | 91.66% |